Metastatic Non-small Cell Lung Cancer With MTAP Deletion
Oncology·MeSH: Lung Neoplasms
2 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Pemetrexed | BRISTOL MYERS SQUIBB CO (BMY) |
Phase 4(1)
| Drug | Company |
|---|---|
| BMS-986504 | BRISTOL MYERS SQUIBB CO (BMY) |
Compare drugs
Frequently asked questions
How many drugs are in development for Metastatic Non-small Cell Lung Cancer With MTAP Deletion?
BioSniper tracks 2 drugs in development for Metastatic Non-small Cell Lung Cancer With MTAP Deletion across 1 company.
How many clinical trials target Metastatic Non-small Cell Lung Cancer With MTAP Deletion?
There are 1 clinical trial targeting Metastatic Non-small Cell Lung Cancer With MTAP Deletion tracked by BioSniper.
Deep-dive into Metastatic Non-small Cell Lung Cancer With MTAP Deletion
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis